Precision Medicine
Broad CGP vs Targeted Hotspot Panels in Oncology
The central mistake in oncology assay selection is treating genomic breadth as a virtue in itself. It is not. A broad…
Actionable intelligence for clinical pathology and diagnostics.
Benchmarked technical analysis, assay updates, and workflow strategies across diagnostic subspecialties.
The central mistake in oncology assay selection is treating genomic breadth as a virtue in itself. It is not. A broad…
Turnaround time is a cost center. In advanced non-small-cell lung cancer, published clinical data demonstrate that plasma ctDNA…